CompletedNot Applicable

Predictors of Myasthenia Gravis Outcome Following Thoracoscopic Thymectomy: Comparative Study Between Thymomatous and Non-Thymomatous Patients

Egypt100 participantsStarted 2022-01-01

Plain-language summary

This study aimed to assess and compare predictors of outcome in patients with thymomatous and non-thymomatous MG undergoing Thoracoscopic thymectomy.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Both sexes. * Confirmed diagnosis of Myasthenia Gravis (MG). * Underwent Thoracoscopic thymectomy. * Availability of complete preoperative and postoperative records, including imaging and histopathology. * Minimum follow-up of 9 months post-surgery. Exclusion Criteria: * Patients who underwent thymectomy for indications other than MG. * Incomplete medical records or loss to follow-up before outcome assessment. * Patients with concomitant neuromuscular disorders other than MG

What they're measuring

Proportion of patients achieving complete stable remission

Timeframe: 12 months post-procedure

Trial details

NCT IDNCT07319689

SponsorTanta University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2025-12-18

View on ClinicalTrials.gov More Predictor trials